AZD2373 subcutaneous injection
Sponsors
AstraZeneca
Conditions
Healthy Volunteers
Phase 1
A First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD2373 After Single Dose Administration in Healthy Male Subjects of African Ancestry.
CompletedNCT04269031
Start: 2020-02-13End: 2021-08-31Updated: 2023-07-10
A Study to Assess Safety, Tolerability, PK and PD of AZD2373 in Healthy Male Participants of Sub-Saharan West African Ancestry
CompletedNCT05351047
Start: 2022-04-04End: 2023-07-06Updated: 2023-08-07